An aryl isonitrile compound with an improved physicochemical profile that is effective in two mouse models of multidrug-resistant Staphylococcus aureus infection
ConclusionsIn summary, compound 35 was identified as a new lead aryl isonitrile compound that warrants further investigation as a novel antibacterial agent.
Source: Journal of Global Antimicrobial Resistance - Category: Infectious Diseases Source Type: research
More News: Antimicrobial Resistance | Databases & Libraries | Gastroenterology | Infectious Diseases | Liver | MRSA | Multidrug Resistance | Skin | Staphylococcus Aureus | Study | Superbugs | Toxicology | Urology & Nephrology